Okilactomycin, a novel antibiotic produced by a Streptomyces species. I. Taxonomy, fermentation, isolation and characterization

J Antibiot (Tokyo). 1987 Nov;40(11):1475-82. doi: 10.7164/antibiotics.40.1475.

Abstract

Okilactomycin, a novel antibiotic, was isolated from the culture filtrate of a strain of actinomycetes. The producing organism, strain YP-02908L, was identified as Streptomyces griseoflavus subsp. zamamiensis subsp. nov. The antibiotic was extracted with ethyl acetate and purified by silica gel column chromatography. It was obtained as colorless prisms from a dichloromethane solution. It exhibited weak antimicrobial activity against Ehrlich ascites carcinoma in vivo. The apparent molecular formula of okilactomycin was determined as C24H32O6. It is a new member of the lactone group antibiotics.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / analysis
  • Anti-Bacterial Agents / isolation & purification*
  • Carcinoma, Ehrlich Tumor / drug therapy
  • Chemical Phenomena
  • Chemistry
  • Female
  • Injections, Intraperitoneal
  • Lactones / analysis
  • Lactones / isolation & purification
  • Lactones / therapeutic use
  • Mice
  • Neoplasms, Experimental / drug therapy

Substances

  • Anti-Bacterial Agents
  • Lactones
  • okilactomycin